Fennec PharmaceuticalsFENC +4.45%54 Days Inventory is 273.83 as of Mar. 2026, which is 5% below its 10-year median of 287.05. GuruFocus rates FENC with a GF Score™ of 54/100 and a GF Value™ of $9.94 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 640 Biotechnology companies, Fennec Pharmaceuticals ranks better than 52.5% on this metric.
The historical rank and industry rank for Fennec Pharmaceuticals's Days Inventory or its related term are showing as below:
FENC'
s Days Inventory Range Over the Past 10 Years
Min: 128.94 Med: 287.05 Max: 2439.57
Current: 176.25
During the past 13 years, Fennec Pharmaceuticals's highest Days Inventory was 2439.57. The lowest was 128.94. And the median was 287.05.
FENC's Days Inventory is ranked better than 52.5% of 640
companies
in the Biotechnology industry
Industry Median: 184.145
vs FENC: 176.25
Fennec Pharmaceuticals's Days Inventory
declined
from Mar. 2025 (301.39) to Mar. 2026 (273.83).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Fennec Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.33.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Fennec Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.11.
Fennec Pharmaceuticals (NAS:FENC) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Fennec Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Fennec Pharmaceuticals's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Fennec Pharmaceuticals Days Inventory Related Terms
Fennec Pharmaceuticals Days Inventory Historical Data
* Premium members only.
The historical data trend for Fennec Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FENC vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Fennec Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fennec Pharmaceuticals Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Fennec Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Fennec Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fennec Pharmaceuticals (FENC) has a Days Inventory of 273.83 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Fennec Pharmaceuticals and its competitors. This is near median its historical median of 287.05. Over the past decade, Fennec Pharmaceuticals' Days Inventory has ranged from 128.94 to 2,439.57. According to the industry distribution chart, Fennec Pharmaceuticals ranks #304 out of 640 companies in the Biotechnology industry, placing it in the top 47.5%.
Is Fennec Pharmaceuticals' Days Inventory too high?
Fennec Pharmaceuticals' current Days Inventory of 273.83 is near median its 10-year median of 287.05. Over the past 10 years, this metric has ranged from a low of 128.94 to a high of 2,439.57. The Biotechnology industry median Days Inventory is 184.15. Fennec Pharmaceuticals' value of 273.83 is 48.7% above this industry median. Based on the distribution chart, Fennec Pharmaceuticals ranks #304 out of 640 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Fennec Pharmaceuticals has a GF Score™ of 54/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fennec Pharmaceuticals' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Fennec Pharmaceuticals ranks #304 out of 640 companies for Days Inventory. This puts Fennec Pharmaceuticals in the upper half of its industry. The industry median Days Inventory is 184.15. Fennec Pharmaceuticals' value of 273.83 is 48.7% above this benchmark. Historically, Fennec Pharmaceuticals' own Days Inventory has ranged from 128.94 to 2,439.57 over the past decade. While the company's 10-year median is 287.05 vs. the industry median of 184.15, Fennec Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 184.15, based on 640 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fennec Pharmaceuticals's current Days Inventory of 273.83 is 48.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Fennec Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Inventory is 184.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fennec Pharmaceuticals's current Days Inventory is 273.83, which is near median its own 10-year median of 287.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fennec Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Fennec Pharmaceuticals (FENC) is currently considered Modestly Overvalued. The stock's GF Value™ is $9.94, compared to a current price of $11.02 — trading 10.9% above its estimated fair value. The current Days Inventory is 273.83, which is near median its 10-year median of 287.05 and 48.7% above the Biotechnology industry median of 184.15. Fennec Pharmaceuticals' overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Fennec Pharmaceuticals (FENC), the current Days Inventory is 273.83 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fennec Pharmaceuticals (FENC) Overvalued in 2026?
Based on GuruFocus' analysis, Fennec Pharmaceuticals stock appears to be overvalued.
The current stock price of $11.02 is trading 10.9% above its estimated GF Value™ of $9.94.
GuruFocus considers Fennec Pharmaceuticals to be Modestly Overvalued.
Key valuation signals for FENC:
Days Inventory: 273.83 (near median its 10-year median of 287.05)
GF Value™: $9.94 vs. price of $11.02 (10.9% above fair value)
Industry Position: 48.7% above the Biotechnology median (#304 of 640)
No single metric tells the full story. See the FENC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
54GF Score
Get the complete analysis for FENC
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FENC has been successfully added to your 
